HighGravityDataMolina Healthcare — Feb 5, 2025 release
Fiscal 2024 fourth-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001179929-25-000020
Showing in the filing
Estimated Non-Recurring Costs for Recently Announced Acquisitions
“approximately $20 million”
Period
No period stated
Measure
GAAP-tied
Source
Prose
All guidance in this release · 28
Premium revenue for FY2025
“approximately $42 billion”
Adjusted earnings for FY2025
“at least $24.50 per diluted share”
Implementation Costs for Duals Contract Wins for FY2025
“approximately $1.00 per diluted share”
Adjusted EPS Growth (yield, excluding implem… for FY2025
“approximately 13% growth over 2024”
New Store Embedded Earnings for FY2026
“$7.75 per diluted share”
GAAP earnings per share for FY2025
“at least $22.50 per share”
GAAP EPS for FY2025
“at least $22.50 per share”
Adjusted EPS Growth (as reported) for FY2025
“8% growth over the full year 2024”
Premium Revenue for FY2025
“$42.0B”
Total Revenue for FY2025
“$44.0B”
GAAP Net Income for FY2025
“$1,251M”
Adjusted Net Income for FY2025
“$1,362M”
GAAP EPS - Diluted for FY2025
“>$22.50”
Adjusted EPS - Diluted for FY2025
“>$24.50”
Diluted weighted average shares for FY2025
“55.6M”
Year End Total Membership for FY2025
“5.9M”
Medicaid Membership for FY2025
“5.0M”
Year End Total Membership - Medicaid for FY2025
“5.0M”
Medicare Membership for FY2025
“250K”
Year End Total Membership - Medicare for FY2025
“250K”
Marketplace Membership for FY2025
“580K”
Year End Total Membership - Marketplace for FY2025
“580K”
MCR for FY2025
“88.7%”
GAAP G&A Ratio for FY2025
“7.2%”
Adjusted G&A Ratio for FY2025
“7.0%”
Effective Tax Rate for FY2025
“25.3%”
Adjusted After-tax Margin for FY2025
“3.1%”
Estimated Non-Recurring Costs for Recently A…
“approximately $20 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
Management is unable to reconcile this measure to the growth in GAAP earnings per share, the most directly comparable GAAP measure, without unreasonable effort due to the unknown impact from the amortization of intangible assets related to recently announced acquisitions, which cannot be determined until purchase accounting valuations are completed. Non-recurring costs associated with the recently announced acquisitions are estimated at approximately $20 million. -END-
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.